Funder
Taisho Toyama Pharmaceutical Co., Ltd.
Pfizer Japan
Eisai Co., Ltd.
Daiichi-Sankyo Co., Ltd.
Astellas Pharma
Dainippon Sumitomo Pharma Co., Ltd.
Shionogi & Co. Ltd.
Meiji Seika Pharma Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference32 articles.
1. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial;Kullberg;Lancet,2005
2. Treatment of invasive candidiasis in the elderly: a review;Flevari;Clin Interv Aging,2013
3. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011;Asmundsdottir;J Clin Microbiol,2013
4. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011;Cleveland;Clin Infect Dis,2012
5. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008;Playford;J Hosp Infect,2010
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献